Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
postoperative adjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Small-cell Lung Cancer
1 trial -
prazosin hydrochloride
United Therapeutics Europe Ltd
Alcohol Use Disorders
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
Colonoscopy: Bowel Preparation
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
IBD (Inflammatory Bowel Disease)
1 trial -
preoperative oral carbohydrate drink
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
probiotics
The First People's Hospital of Lianyungang
Ulcerative Colitis
1 trial -
prochlorperazine and benadryl IV
United Therapeutics Europe Ltd
Acute Migraine Headache
1 trial -
progastrin
Grace Therapeutics
Colon Cancer Screening
1 trial -
propofol
The First People's Hospital of Lianyungang
Anesthesia
1 trial -
radiochemotherapy 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Non Small Cell Lung Cancer
1 trial -
remimazolam
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthetic Drug Adverse Reaction
1 trial -
remimazolam combined with remifentanil
The First People's Hospital of Lianyungang
Difficult or Failed Intubation
1 trial -
rice formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial -
routine aspirin and heparin treatment
The First People's Hospital of Lianyungang
Acupuncture
1 trial -
salbutamol
The First People's Hospital of Lianyungang
Liver Transplantation
1 trial -
saline
United Therapeutics Europe Ltd
Chorioamnionitis
1 trial -
sevelamer hydrochloride
The University of Hong Kong
Endstage Renal Disease
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
sodium bicarbonate Ringer's solution
The First People's Hospital of Lianyungang
Hepatic Ischemia
1 trial -
solu medrol
The First People's Hospital of Lianyungang
Immunosuppression
1 trial -
standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT
The First People's Hospital of Lianyungang
Tumor
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
stereotactic radiosurgery
United Therapeutics Europe Ltd
Head and Neck Cancer
1 trial -
steroid therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sudden Hearing Loss
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources